Itolizumab (Anti-Human CD6 Recombinant Antibody) is a recombinant anti-CD6 monoclonal antibody that targets the extracellular SRCR distal domain 1 of CD6, thereby slowing T cell proliferation and inhibiting pro-inflammatory cytokine production. Itolizuma
CAS Number:
[1116433-11-4]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted